Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against <it>Plasmodium falciparum</it>
<p>Abstract</p> <p>Background</p> <p>Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significant problem, but there is an...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-05-01
|
| Series: | Malaria Journal |
| Online Access: | http://www.malariajournal.com/content/9/1/139 |